Profile picture

Professor Eugene Yang

University of Washington, Seattle (United States of America)
Membership: ESC Professional Member EAPC Member
Follow
Biography
Eugene Yang, M.D., M.S., F.A.C.C. is a Professor in the Division of Cardiology and holds the Carl and Renee Behnke Endowed Chair for Asian Health at the University of Washington School of Medicine. He is the chair of the ACC Section Steering Committee and immediate past chair of the ACC Prevention of Cardiovascular Disease Section. He is co-director of the UW Medicine Cardiovascular Wellness and Prevention Program. His research focuses on cardiovascular risk assessment and new blood pressure measurement technologies. Dr. Yang earned his undergraduate and graduate degrees from Stanford and his M.D from the University of Pennsylvania School of Medicine. He completed his internal medicine residency and cardiology fellowship at Stanford.
Logo ESC

Contributor content

Guidelines in practice: hypertension on both sides of the Atlantic
Session
Guidelines in practice: hypertension on both sides of the Atlantic
25 April 2026
Congenital and coronary anomalies: rare but risky
Session
Congenital and coronary anomalies: rare but risky
24 April 2026
Sex differences (1)
Session
Sex differences (1)
30 August 2025
Risk factors (3)
Session
Risk factors (3)
30 August 2025
Discover! Assessing the accuracy of a ring-type cuffless blood pressure device across postures
Session
Discover! Assessing the accuracy of a ring-type cuffless blood pressure device across postures
29 August 2025
Challenging cases in lipid management
Session
Challenging cases in lipid management
4 April 2025
Clinical Case Management: impact of comorbidities on personalised care for hypertension
Session
Clinical Case Management: impact of comorbidities on personalised care for hypertension
2 September 2024
Refining risk stratification: what works best in primary prevention?
Session
Refining risk stratification: what works best in primary prevention?
31 August 2024
Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?
Session
Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?
30 August 2024
Challenging cases in dyslipidaemia
Session
Challenging cases in dyslipidaemia
26 April 2024

ESC 365 is supported by